Ousted CytoDyn CEO Pourhassan indicted for alleged securities fraud


Pourhassan allegedly made false and misleading representations about the company's investigational drug, leronlimab.

Previous Wells Fargo to close Nokomis branch in Minneapolis
Next Son of a Butcher to open third DFW location in Grapevine early next year